ORGENTEC Autoimmunity Blog

Covering Autoimmune Diseases

Findings of autoantibodies in COVID-19 patients

Dysregulation of the immune system and autoimmune processes play a key role in severe and long-term course of COVID-19 infections. Research has shown that autoantibodies against phospholipids, anti-cardiolipin and anti-beta-2-glycoprotein, may contribute significantly to COVID-19 related autoimmunity and disease severity. Understanding how these antibodies trigger the thrombotic manifestations of the disease is important to improve patient management and to understand the underlying pathophysiology of SARS-CoV-2 infection.
Doctors’ awareness of autoantibodies promoting COVID-19 disease and determination of these autoantibodies with reliable laboratory tests will benefit the patients.        

Updated: 24. February 2021 — 17:13

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Autoimmunity Blog © 2020